Acne Vulgaris Treatment Market Growth, Trends and Demands Research Report and Forecast 2026

0

U.S. is expected to be the largest market for acne vulgaris treatment products over the forecast period

According to a study published in the British Journal of Dermatology in 2015, 9.4% of global population was estimated to be affected by acne. Moreover, globally, acne is the eight most prevalent disease. The U.S. is the largest market for acne vulgaris treatment products. According to study by National Institute of Health (NIH), in 2013, over US$ 3 Billion was spent for treating acne vulgaris in the U.S. In 2014, according to American Academy of Dermatology, the number of acne vulgaris patient aged 25 years and above, especially women, is rising significantly.  Furthermore, low awareness regarding the factors causing acne is another factor leading to increasing prevalence acne vulgaris.

Treatment for acne on an average lasts for two years, therefore companies capitalize on this and earn sustainable revenue from acne treatment products. Majority of the population suffering from acne prefer OTC products as first line therapy. However, some have to visit dermatologist to cure acne vulgaris on account of ineffective result from OTC products.

Get a PDF Sample of Acne Vulgaris TreatmentMarket Research Report at: https://www.coherentmarketinsights.com/insight/request-sample/1260

Acne Vulgaris Treatment market report provides key statistics on the market status of the Acne Vulgaris Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Acne Vulgaris Treatment industry. The Acne Vulgaris Treatment market report also presents the vendor landscape and a corresponding detailed analysis of the major vendors operating in the market.

Key Vendors of Acne Vulgaris Treatment Market: Key players in the global acne vulgaris treatment market are Allergan plc, GlaxoSmithKline plc, Valeant Pharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., Bayer AG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.

Acne Vulgaris Treatment market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.

Regions of Acne Vulgaris Treatment market:

• Americas

• APAC

• EMEA

Ask for customization: 

Purchase

In the end, the report makes some important proposals for a new project of Acne Vulgaris Treatment Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2016-2020 global Acne Vulgaris Treatment industry covering all important parameters.

Acne Vulgaris Treatment driver

Acne Vulgaris Treatment challenge

Acne Vulgaris Treatment trend

This, in turn, makes it a highly lucrative market for acne vulgaris treatment products. India also has high glycemic index diet, which is further expected to aid in growth of the market over the forecast period. Manufacturers are also focusing on developing products for scarring, resulting from acne. New treatments such as cosmetic (laser, chemical peel, and photodynamic therapy) and surgical procedures are been developed for treatment of scarring.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1260

 

Share.